Europe IVD In Cardiology And Neurology Market Size, Share & Trends Analysis Report By Product Type, By End Use, By Technology (Immunoassays, Molecular Diagnostics, Hematology, and Others), By Country and Growth Forecast, 2023 - 2030

The Europe IVD In Cardiology And Neurology Market would witness market growth of 8.9% CAGR during the forecast period (2023-2030).

The Germany market dominated the Europe IVD In Cardiology And Neurology Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,778 million by 2030. The UK market is exhibiting a CAGR of 7.9% during (2023 - 2030). Additionally, The France market would experience a CAGR of 9.8% during (2023 - 2030).

The integration of Artificial Intelligence (AI) has transformed the landscape of IVD in cardiology and neurology. AI algorithms enhance diagnostic data interpretation, improving test results' accuracy and efficiency. The utilization of machine learning in image analysis and risk prediction models can significantly transform diagnostic capabilities by furnishing clinicians with cutting-edge decision support tools.

Furthermore, an important benefit of integrating AI into IVD is the significant enhancement in the precision and effectiveness of test outcomes. The rapid processing of enormous volumes of data by machine learning algorithms reduces the probability of human error and improves the accuracy of diagnostic evaluations. In cardiology, AI aids in interpreting cardiac imaging, electrocardiograms (ECGs), and biomarker data. Neurology supports the analysis of neuroimaging, genetic data, and cerebrospinal fluid markers, providing a more comprehensive understanding of neurological conditions.

The European Union has witnessed a continuous commitment to increasing healthcare budgets. This enhanced funding allows for investments in state-of-the-art diagnostic technologies, including those related to In vitro diagnostics. According to the Eurostat data, Germany had the highest level of current healthcare expenditure among the EU Member States, valued at €432 billion in 2020. Following Italy ($160 billion) and Spain ($120 billion) in terms of current healthcare spending was France ($281 billion). Thus, the increasing healthcare expenditure in Europe is expected to boost the region's demand for In vitro diagnostics in cardiology and neurology.  

Free Valuable Insights: The Global IVD In Cardiology And Neurology Market will Hit USD 29.9 Billion by 2030, at a CAGR of 9.3%

Based on Product Type, the market is segmented into Reagents & Consumables, Instruments, and Software & Services. Based on End Use, the market is segmented into Hospitals, Clinical Laboratories, and Others. Based on Technology, the market is segmented into Immunoassays, Molecular Diagnostics, Hematology, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

• Thermo Fisher Scientific, Inc.
• F.Hoffmann-La Roche Ltd.
• Sysmex Corporation
• Siemens Healthineers AG (Siemens AG)
• Quest Diagnostics Incorporated
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Danaher Corporation (Beckman Coulter, Inc.)
• Becton, Dickinson and Company
• Natera, Inc.

Europe IVD In Cardiology And Neurology Market Report Segmentation

By Product Type

• Reagents & Consumables
• Instruments
• Software & Services

By End Use

• Hospitals
• Clinical Laboratories
• Others

By Technology

• Immunoassays
• Molecular Diagnostics
• Hematology
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe IVD In Cardiology And Neurology Market, by Product Type
1.4.2 Europe IVD In Cardiology And Neurology Market, by End Use
1.4.3 Europe IVD In Cardiology And Neurology Market, by Technology
1.4.4 Europe IVD In Cardiology And Neurology Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. Europe IVD In Cardiology And Neurology Market by Product Type
4.1 Europe Reagents & Consumables Market by Country
4.2 Europe Instruments Market by Country
4.3 Europe Software & Services Market by Country

Chapter 5. Europe IVD In Cardiology And Neurology Market by End-use
5.1 Europe Hospitals Market by Country
5.2 Europe Clinical Laboratories Market by Country
5.3 Europe Others Market by Country

Chapter 6. Europe IVD In Cardiology And Neurology Market by Technology
6.1 Europe Immunoassays Market by Country
6.2 Europe Molecular Diagnostics Market by Country
6.3 Europe Hematology Market by Country
6.4 Europe Others Market by Country

Chapter 7. Europe IVD In Cardiology And Neurology Market by Country
7.1 Germany IVD In Cardiology And Neurology Market
7.1.1 Germany IVD In Cardiology And Neurology Market by Product Type
7.1.2 Germany IVD In Cardiology And Neurology Market by End-use
7.1.3 Germany IVD In Cardiology And Neurology Market by Technology
7.2 UK IVD In Cardiology And Neurology Market
7.2.1 UK IVD In Cardiology And Neurology Market by Product Type
7.2.2 UK IVD In Cardiology And Neurology Market by End-use
7.2.3 UK IVD In Cardiology And Neurology Market by Technology
7.3 France IVD In Cardiology And Neurology Market
7.3.1 France IVD In Cardiology And Neurology Market by Product Type
7.3.2 France IVD In Cardiology And Neurology Market by End-use
7.3.3 France IVD In Cardiology And Neurology Market by Technology
7.4 Russia IVD In Cardiology And Neurology Market
7.4.1 Russia IVD In Cardiology And Neurology Market by Product Type
7.4.2 Russia IVD In Cardiology And Neurology Market by End-use
7.4.3 Russia IVD In Cardiology And Neurology Market by Technology
7.5 Spain IVD In Cardiology And Neurology Market
7.5.1 Spain IVD In Cardiology And Neurology Market by Product Type
7.5.2 Spain IVD In Cardiology And Neurology Market by End-use
7.5.3 Spain IVD In Cardiology And Neurology Market by Technology
7.6 Italy IVD In Cardiology And Neurology Market
7.6.1 Italy IVD In Cardiology And Neurology Market by Product Type
7.6.2 Italy IVD In Cardiology And Neurology Market by End-use
7.6.3 Italy IVD In Cardiology And Neurology Market by Technology
7.7 Rest of Europe IVD In Cardiology And Neurology Market
7.7.1 Rest of Europe IVD In Cardiology And Neurology Market by Product Type
7.7.2 Rest of Europe IVD In Cardiology And Neurology Market by End-use
7.7.3 Rest of Europe IVD In Cardiology And Neurology Market by Technology

Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.6 SWOT Analysis
8.2 F. Hoffmann-La Roche Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Sysmex Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 Siemens Healthineers AG (Siemens AG)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 Quest Diagnostics Incorporated
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Acquisition and Mergers:
8.5.5 SWOT Analysis
8.6 Abbott Laboratories
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Bio-Rad laboratories, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 Danaher Corporation (Beckman Coulter)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 Becton, Dickinson, and Company
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Natera Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis

TABLE 1 Europe IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 2 Europe IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 3 Europe IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 4 Europe IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 5 Europe Reagents & Consumables Market by Country, 2019 - 2022, USD Million
TABLE 6 Europe Reagents & Consumables Market by Country, 2023 - 2030, USD Million
TABLE 7 Europe Instruments Market by Country, 2019 - 2022, USD Million
TABLE 8 Europe Instruments Market by Country, 2023 - 2030, USD Million
TABLE 9 Europe Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 10 Europe Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 11 Europe IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 12 Europe IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 13 Europe Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 14 Europe Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 15 Europe Clinical Laboratories Market by Country, 2019 - 2022, USD Million
TABLE 16 Europe Clinical Laboratories Market by Country, 2023 - 2030, USD Million
TABLE 17 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 18 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 19 Europe IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 20 Europe IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 21 Europe Immunoassays Market by Country, 2019 - 2022, USD Million
TABLE 22 Europe Immunoassays Market by Country, 2023 - 2030, USD Million
TABLE 23 Europe Molecular Diagnostics Market by Country, 2019 - 2022, USD Million
TABLE 24 Europe Molecular Diagnostics Market by Country, 2023 - 2030, USD Million
TABLE 25 Europe Hematology Market by Country, 2019 - 2022, USD Million
TABLE 26 Europe Hematology Market by Country, 2023 - 2030, USD Million
TABLE 27 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 28 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 29 Europe IVD In Cardiology And Neurology Market by Country, 2019 - 2022, USD Million
TABLE 30 Europe IVD In Cardiology And Neurology Market by Country, 2023 - 2030, USD Million
TABLE 31 Germany IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 32 Germany IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 33 Germany IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 34 Germany IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 35 Germany IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 36 Germany IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 37 Germany IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 38 Germany IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 39 UK IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 40 UK IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 41 UK IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 42 UK IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 43 UK IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 44 UK IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 45 UK IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 46 UK IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 47 France IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 48 France IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 49 France IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 50 France IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 51 France IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 52 France IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 53 France IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 54 France IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 55 Russia IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 56 Russia IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 57 Russia IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 58 Russia IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 59 Russia IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 60 Russia IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 61 Russia IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 62 Russia IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 63 Spain IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 64 Spain IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 65 Spain IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 66 Spain IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 67 Spain IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 68 Spain IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 69 Spain IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 70 Spain IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 71 Italy IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 72 Italy IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 73 Italy IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 74 Italy IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 75 Italy IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 76 Italy IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 77 Italy IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 78 Italy IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 79 Rest of Europe IVD In Cardiology And Neurology Market, 2019 - 2022, USD Million
TABLE 80 Rest of Europe IVD In Cardiology And Neurology Market, 2023 - 2030, USD Million
TABLE 81 Rest of Europe IVD In Cardiology And Neurology Market by Product Type, 2019 - 2022, USD Million
TABLE 82 Rest of Europe IVD In Cardiology And Neurology Market by Product Type, 2023 - 2030, USD Million
TABLE 83 Rest of Europe IVD In Cardiology And Neurology Market by End-use, 2019 - 2022, USD Million
TABLE 84 Rest of Europe IVD In Cardiology And Neurology Market by End-use, 2023 - 2030, USD Million
TABLE 85 Rest of Europe IVD In Cardiology And Neurology Market by Technology, 2019 - 2022, USD Million
TABLE 86 Rest of Europe IVD In Cardiology And Neurology Market by Technology, 2023 - 2030, USD Million
TABLE 87 Key Information – Thermo Fisher Scientific, Inc.
TABLE 88 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 89 Key Information – Sysmex Corporation
TABLE 90 Key Information – Siemens Healthineers AG
TABLE 91 Key information – Quest Diagnostics Incorporated
TABLE 92 Key Information – Abbott Laboratories
TABLE 93 Key Information – Bio-Rad Laboratories, Inc.
TABLE 94 Key Information – Danaher Corporation
TABLE 95 Key Information – Becton, Dickinson and Company
TABLE 96 Key Information – Natera Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe IVD In Cardiology And Neurology Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting IVD In Cardiology And Neurology Market
FIG 4 Porter’s Five Forces Analysis - IVD In Cardiology And Neurology Market
FIG 5 Europe IVD In Cardiology And Neurology Market share by Product Type, 2022
FIG 6 Europe IVD In Cardiology And Neurology Market share by Product Type, 2030
FIG 7 Europe IVD In Cardiology And Neurology Market by Product Type, 2019 - 2030, USD Million
FIG 8 Europe IVD In Cardiology And Neurology Market share by End-use, 2022
FIG 9 Europe IVD In Cardiology And Neurology Market share by End-use, 2030
FIG 10 Europe IVD In Cardiology And Neurology Market by End-use, 2019 - 2030, USD Million
FIG 11 Europe IVD In Cardiology And Neurology Market share by Technology, 2022
FIG 12 Europe IVD In Cardiology And Neurology Market share by Technology, 2030
FIG 13 Europe IVD In Cardiology And Neurology Market by Technology, 2019 - 2030, USD Million
FIG 14 Europe IVD In Cardiology And Neurology Market share by Country, 2022
FIG 15 Europe IVD In Cardiology And Neurology Market share by Country, 2030
FIG 16 Europe IVD In Cardiology And Neurology Market by Country, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: Thermo Fisher Scientific, Inc.
FIG 18 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 19 SWOT Analysis: Sysmex Corporation
FIG 20 SWOT Analysis: Siemens Healthineers AG
FIG 21 SWOT Analysis: Quest Diagnostics Incorporated
FIG 22 SWOT Analysis: Abbott Laboratories
FIG 23 SWOT Analysis: Bio-Rad Laboratories, Inc.
FIG 24 SWOT Analysis: Danaher Corporation
FIG 25 SWOT Analysis: Becton, Dickinson and company
FIG 26 Swot Analysis: Natera, Inc.